OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Characterization of Lipid and Lipid Droplet Metabolism in Human HCC
Nikolaus Berndt, Johannes Eckstein, Niklas Heucke, et al.
Cells (2019) Vol. 8, Iss. 5, pp. 512-512
Open Access | Times Cited: 83
Nikolaus Berndt, Johannes Eckstein, Niklas Heucke, et al.
Cells (2019) Vol. 8, Iss. 5, pp. 512-512
Open Access | Times Cited: 83
Showing 1-25 of 83 citing articles:
Lipid droplets provide metabolic flexibility for cancer progression
Rémi Safi, Pablo Menéndez, Albert Pol
FEBS Letters (2024) Vol. 598, Iss. 10, pp. 1301-1327
Open Access | Times Cited: 17
Rémi Safi, Pablo Menéndez, Albert Pol
FEBS Letters (2024) Vol. 598, Iss. 10, pp. 1301-1327
Open Access | Times Cited: 17
Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review
Bo Hu, Jianzhen Lin, Xiaobo Yang, et al.
Cell Proliferation (2020) Vol. 53, Iss. 3
Open Access | Times Cited: 109
Bo Hu, Jianzhen Lin, Xiaobo Yang, et al.
Cell Proliferation (2020) Vol. 53, Iss. 3
Open Access | Times Cited: 109
A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression
Kequan Xu, Peng Xia, Xiangdong Gongye, et al.
Molecular Metabolism (2022) Vol. 63, pp. 101540-101540
Open Access | Times Cited: 43
Kequan Xu, Peng Xia, Xiangdong Gongye, et al.
Molecular Metabolism (2022) Vol. 63, pp. 101540-101540
Open Access | Times Cited: 43
MS3 Imaging Enables the Simultaneous Analysis of Phospholipid C═C and sn-Position Isomers in Tissues
X. Guo, Wenbo Cao, Xiaomin Fan, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 10, pp. 4259-4265
Closed Access | Times Cited: 10
X. Guo, Wenbo Cao, Xiaomin Fan, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 10, pp. 4259-4265
Closed Access | Times Cited: 10
Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma
Christa Buechler, Charalampos Aslanidis
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2020) Vol. 1865, Iss. 5, pp. 158658-158658
Closed Access | Times Cited: 67
Christa Buechler, Charalampos Aslanidis
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2020) Vol. 1865, Iss. 5, pp. 158658-158658
Closed Access | Times Cited: 67
Friend or Foe: Lipid Droplets as Organelles for Protein and Lipid Storage in Cellular Stress Response, Aging and Disease
Florian Geltinger, Lukas Schartel, Markus Wiederstein, et al.
Molecules (2020) Vol. 25, Iss. 21, pp. 5053-5053
Open Access | Times Cited: 56
Florian Geltinger, Lukas Schartel, Markus Wiederstein, et al.
Molecules (2020) Vol. 25, Iss. 21, pp. 5053-5053
Open Access | Times Cited: 56
MicroRNA-377-3p inhibits hepatocellular carcinoma growth and metastasis through negative regulation of CPT1C-mediated fatty acid oxidation
Ting Zhang, Yanan Zhang, Jie Liu, et al.
Cancer & Metabolism (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 32
Ting Zhang, Yanan Zhang, Jie Liu, et al.
Cancer & Metabolism (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 32
Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC
Miriam Longo, Erika Paolini, Marica Meroni, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4173-4173
Open Access | Times Cited: 38
Miriam Longo, Erika Paolini, Marica Meroni, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4173-4173
Open Access | Times Cited: 38
LPCAT1 overexpression promotes the progression of hepatocellular carcinoma
Rong‐Quan He, Jian‐Di Li, Xiu‐Fang Du, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 35
Rong‐Quan He, Jian‐Di Li, Xiu‐Fang Du, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 35
Lipid Droplet-Targeting near-infrared carbon dots with High-Specificity Dual-Report function for diagnosing hepatocellular carcinoma and evaluating its pharmacodynamics
Junli Wang, Yuanqiang Sun, Jingyu Hu, et al.
Chemical Engineering Journal (2023) Vol. 474, pp. 145762-145762
Closed Access | Times Cited: 15
Junli Wang, Yuanqiang Sun, Jingyu Hu, et al.
Chemical Engineering Journal (2023) Vol. 474, pp. 145762-145762
Closed Access | Times Cited: 15
Lipid Droplets in Disease
Paul Dalhaimer
Cells (2019) Vol. 8, Iss. 9, pp. 974-974
Open Access | Times Cited: 40
Paul Dalhaimer
Cells (2019) Vol. 8, Iss. 9, pp. 974-974
Open Access | Times Cited: 40
The Role of the NLRP3 Inflammasome in HCC Carcinogenesis and Treatment: Harnessing Innate Immunity
Stavros P. Papadakos, Nikolaos Dedes, Elias Kouroumalis, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3150-3150
Open Access | Times Cited: 19
Stavros P. Papadakos, Nikolaos Dedes, Elias Kouroumalis, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3150-3150
Open Access | Times Cited: 19
RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4
Chun Wang, Zhihang Chen, Yun Yi, et al.
Oncogene (2023) Vol. 43, Iss. 5, pp. 328-340
Closed Access | Times Cited: 11
Chun Wang, Zhihang Chen, Yun Yi, et al.
Oncogene (2023) Vol. 43, Iss. 5, pp. 328-340
Closed Access | Times Cited: 11
Recreating metabolic interactions of the tumour microenvironment
Rodrigo Curvello, Nikolaus Berndt, Sandra Hauser, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 6, pp. 518-532
Closed Access | Times Cited: 4
Rodrigo Curvello, Nikolaus Berndt, Sandra Hauser, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 6, pp. 518-532
Closed Access | Times Cited: 4
Clinical Significance of Acyl-CoA Dehydrogenase Short Chain and Its Anti-tumor Role in Hepatocellular Carcinoma by Inhibiting Canonical Wnt/β-Catenin Pathway
Jiawei Gu, Zhipeng Cao, Gengming Niu, et al.
Digestive Diseases and Sciences (2025)
Closed Access
Jiawei Gu, Zhipeng Cao, Gengming Niu, et al.
Digestive Diseases and Sciences (2025)
Closed Access
LRP11 facilitates lipid metabolism and malignancy in hepatocellular carcinoma by stabilizing RACK1 through USP5 regulation
Litao Liang, Wenbo Jia, Jinyi Wang, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Litao Liang, Wenbo Jia, Jinyi Wang, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Metabolic Profiling Analysis of Patients With Coronary Heart Disease Undergoing Xuefu Zhuyu Decoction Treatment
Tianqi Tao, Tao He, Xiao-Reng Wang, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 30
Tianqi Tao, Tao He, Xiao-Reng Wang, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 30
The prognostic value of an autophagy-related lncRNA signature in hepatocellular carcinoma
Shiming Yang, Yaping Zhou, Xiangxin Zhang, et al.
BMC Bioinformatics (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 26
Shiming Yang, Yaping Zhou, Xiangxin Zhang, et al.
BMC Bioinformatics (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 26
Dihydroartemisinin reduced lipid droplet deposition by YAP1 to promote the anti-PD-1 effect in hepatocellular carcinoma
Liyuan Hao, Yinglin Guo, Qing Peng, et al.
Phytomedicine (2021) Vol. 96, pp. 153913-153913
Closed Access | Times Cited: 25
Liyuan Hao, Yinglin Guo, Qing Peng, et al.
Phytomedicine (2021) Vol. 96, pp. 153913-153913
Closed Access | Times Cited: 25
GDF11 rapidly increases lipid accumulation in liver cancer cells through ALK5-dependent signaling
Jan Fröhlich, Tommaso Mazza, Cyril Sobolewski, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2021) Vol. 1866, Iss. 6, pp. 158920-158920
Open Access | Times Cited: 24
Jan Fröhlich, Tommaso Mazza, Cyril Sobolewski, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2021) Vol. 1866, Iss. 6, pp. 158920-158920
Open Access | Times Cited: 24
Lipidomic biomarkers: Potential mediators of associations between urinary bisphenol A exposure and colorectal cancer
Xu Hong, Gengfu Wang, Xingcun Liu, et al.
Journal of Hazardous Materials (2021) Vol. 427, pp. 127863-127863
Closed Access | Times Cited: 24
Xu Hong, Gengfu Wang, Xingcun Liu, et al.
Journal of Hazardous Materials (2021) Vol. 427, pp. 127863-127863
Closed Access | Times Cited: 24
Assessing customized multivalent chemokine-binding peptide treatment in a murine model of coxsackievirus B3 myocarditis
Nicolas Kelm, Meike Kespohl, Gintare Smagurauskaite, et al.
Basic Research in Cardiology (2025)
Open Access
Nicolas Kelm, Meike Kespohl, Gintare Smagurauskaite, et al.
Basic Research in Cardiology (2025)
Open Access
MiR-365-3p inhibits lung cancer proliferation and migration via CPT1A-mediated fatty acid oxidation
Dan Xu, Bingya Liu, Lingling Wang
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Dan Xu, Bingya Liu, Lingling Wang
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Deletion of Tfap2a in hepatocytes and macrophages promotes the progression of hepatocellular carcinoma by regulating SREBP1/FASN/ACC pathway and anti-inflammatory effect of IL10
Zhiwei Li, Chun Zhang, Gui‐Xiang Huang, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Zhiwei Li, Chun Zhang, Gui‐Xiang Huang, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Research advances in traditional Chinese medicine formulae and active components targeting lipid metabolism for hepatocellular carcinoma therapy
Liu Yang, Jie Yang, YU Feng-hua, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Liu Yang, Jie Yang, YU Feng-hua, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
